Karen L. Zaderej

CIK 1530968 · CEO · last filed 2026-01-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$48.78M

Companies

3

Total Filings

75

Lifetime Open-Market Net

-$2.13M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EYPT Director 38,500 $12.65 $487.0K $213.2K 11 2026-01-06
AXGN CEO 1,143,788 $42.23 $48.30M -$2.35M 48 2024-03-25
VIVEVE MEDICAL, INC. (VIVE) Delisted Director 62 $0.00 $0 $0 7 2019-11-27

Recent Filings · Page 2 of 8

75 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-08-12 AXGN Notice (144) −200,000 -$2.00M EDGAR
2024-07-12 EYPT Exer (M) +2,000 $0 EDGAR
2024-03-25 AXGN Mixed +71,042 -$301.7K EDGAR
2024-01-09 EYPT Grant (A) $0 EDGAR
2023-10-13 AXGN Grant (A) +22,076 $0 EDGAR
2023-07-12 EYPT Exer (M) +2,000 $0 EDGAR
2023-06-22 EYPT Grant (A) $0 EDGAR
2023-03-20 AXGN Mixed +37,975 $0 EDGAR
2022-12-29 AXGN Exer (M) +4,400 $0 EDGAR
2022-12-16 AXGN Exer (M) +26,746 $136.1K EDGAR
Showing 1120 of 75
Page 2 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.